Food allergies affect 15 million Americans, including 1 in 13 children, at a cost of $25 billion per year. Where there is no official treatment for food allergies, there has been a rise in popularity in Oral Immunotherapy treatment.
If you're not familiar with Oral Immunotherapy, it's when patients are fed small incremental amounts of protein to which they are allergic in a carefully controlled manner over a period of time. Typically immunotherapy takes place in a treatment center, and then is continued at home after 8-10 months. The regular consumption of the allergen can fundamentally change how the body responds to allergens over the course of therapy. Symptom reduction usually occurs within a few months of consistent treatment, although persistent reduction of allergy symptoms has been show when immunotherapeutic treatment continues for 3-5 years.
Intrommune Theraputics is a new biopharmaceutical company based out of NYC that is working to simplify treatment for food allergies by providing convenient new options for food allergy sufferers through their Oral Mucosal Immunotherapy. Essentially, they are working to create an allergy immunotherapy toothpaste which contains peanut allergens. Read more here.